University of the Philippines Manila Technology Transfer and Business Development Office

What University of the Philippines Manila Technology Transfer and Business Development Office does

UPM-TTBDO is the mandated technology transfer and business development office of the University of the Philippines Manila, the Philippines' National Health Sciences Center. Established formally by the UP Board of Regents on August 28, 2019, and tracing its origins to the 2006 UP Manila Intellectual Property Office, the office safeguards intellectual property generated by UP Manila researchers and faculty while moving innovations from laboratory to real-world use. It operates a structured "Seek–Secure–Scale to Serve" methodology covering IP campaigns, advisory services, technology/IP audits, disclosure portals, patent and trademark registration, technology licensing, IP valuation, freedom-to-operate analysis, and business development.

The office manages a portfolio of more than 60 health technologies spanning diagnostics (ETox, CFI/DEFA1 leptospirosis markers, SARS-CoV-2 reagents, genetic markers), therapeutics (Hemoxyther for anemia, anti-dengue herbal preparations, HIV herbal composition), medical devices (AGAPAY robotic exoskeletons, MyBESHIE telepresence robot, SaniPod disinfection cubicle, PAPR, iFIX), digital health solutions (CHITS electronic medical records, RxBox telemedicine, eMED, VR Neuroscreen, COXA deep-learning hip-fracture detection), vaccines (Leptovax), herbal wellness products from the NIRPROMP program (Lagundi, Sambong, Tsaang Gubat, Yerba Buena, Ulasimang Bato, Akapulko), and cosmetics (mosquito repellent mixtures). Several formulations have completed FDA-relevant Phase 1–3 clinical trials, and CHITS has been trademarked and deployed to multiple Local Government Units via the spinout Pivotal Peak Digital Health Solutions.

UPM-TTBDO monetizes this portfolio through licensing agreements with industry (e.g., Hemoxyther licensed to Greenext Lifescience Corporation in November 2020), fee-for-service research collaborations with pharmaceutical and industrial partners (Rohto Pharmaceuticals, D&L Industries), IP advisory and valuation services, and government partnerships for nationwide scale-up (BOI MOU August 2024; DOST-PCHRD co-organization of TeknoLusugan). The office is ISO 9001:2015 certified and has earned ITSO Platinum (2020 and 2026) and ITSO Palladium (2026) awards from IPOPHL. It is staffed by a small team of seven, is government-funded via the UP System, and operates a community-led, event-driven go-to-market centered on its annual TeknoLusugan technology pitching forum (now in its 7th iteration) and inventor recognition events such as Salinlohiya.

Name

University of the Philippines Manila Technology Transfer and Business Development Office

Legal name

University of the Philippines Manila Technology Transfer and Business Development Office

Website

https://ttbdo.upm.edu.ph

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

UPM-TTBDO is the mandated technology transfer office of the University of the Philippines Manila that protects intellectual property and commercializes health innovations (herbal medicines, diagnostics, medical devices, digital health) developed by UP Manila researchers through licensing, research collaborations, and government partnerships.

Ownership category

akta.pro rank

Product category

Technology Transfer and Intellectual Property Services

NAICS

Scientific Research and Development Services (5417)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement) (HLACAIAL)

Keywords

• Technology transfer services
• Intellectual property management
• Health technology licensing
• Academic research commercialization
• Innovation commercialization office

Headquarters

HQ city

Manila

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Technology Licensing and Royalties: The TTBDO generates revenue through licensing agreements with industry partners for UP Manila-developed technologies, including herbal medicines, medical devices, and diagnostics. Revenue is derived from upfront fees, milestone payments, and ongoing royalties under negotiated licensing terms.
2. Research Collaboration Agreements: Fee-for-service research collaboration agreements with private companies (e.g., Rohto Pharmaceuticals, D&L Industries) where industry partners fund specific research and development activities conducted by UP Manila researchers.
3. IP Advisory and Valuation Services: Charges for IP advisory services, technology audits, and IP valuation services provided to the UP Manila community and external parties seeking to assess the commercial potential of technologies.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

UPM-TTBDO is the mandated technology transfer office of the University of the Philippines Manila that safeguards intellectual property of UP Manila researchers and commercializes university-developed health technologies. Its core offerings include IP protection services (patent, copyright, trademark, industrial design, utility model registration), technology licensing and license management, IP valuation, freedom-to-operate analysis, and business development support. The office manages a portfolio of 60+ health technologies spanning diagnostics, therapeutics, digital health, medical devices, vaccines, cosmetics, and herbal medicine formulations developed through its NIRPROMP program.

Product overview

UP Manila Technology Transfer and Business Development Office (UPM-TTBDO) is a technology transfer and intellectual property management office that facilitates the commercialization of health-related innovations developed by UP Manila researchers. The office does not offer a unified software platform but rather manages a diverse portfolio of health technologies across multiple categories including Diagnostics, Health & Wellness, Therapeutics, Digital Health & ICT, Medical Devices, Vaccines, and Cosmetics. The portfolio includes herbal medicine products from NIRPROMP (Lagundi, Sambong, Tsaang Gubat, Yerba Buena), medical devices (iFIX, MyBESHIE, SaniPod, PAPR, AGAPAY Robotic Exoskeletons, Prone Pillow), digital health solutions (CHITS, RxBox, Axel Virtual Care, eMED, VR Neuroscreen), diagnostic tools (ETox, CFI & DEFA1 markers, genetic markers, SARS-CoV-2 reagents), and therapeutic products (Hemoxyther, Anti-Dengue preparations). UPM-TTBDO also provides IP protection services (patent, copyright, trademark, industrial design) and business development services (technology licensing, IP valuation, freedom to operate analysis). The office operates through a 'Seek-Secure-Scale to Serve' model to identify, protect, and commercialize university innovations.

Differentiator

Problem solved

Functional benefit

Products and services

• IP Advisory Services Advisory services for intellectual property protection and management, including patent, trademark, copyright, and industrial design guidance for UP Manila researchers and inventors.
• Technology & IP Audit Audit services for technology and intellectual property assets, helping identify and evaluate innovations for appropriate IP protection and commercialization pathways.
• Disclosure Portal Online portal for researchers and inventors to disclose their innovations and intellectual property to the TTBDO for assessment and processing.
• Technology Licensing Licensing services for UP Manila technologies, facilitating transfer of innovations to industry partners through negotiated agreements with upfront fees, milestone payments, and ongoing royalties.
• IP Valuation Valuation services for intellectual property assets, determining the commercial worth of university innovations for licensing and partnership negotiations.
• Freedom to Operate Analysis Analysis services to determine if a product or technology can be commercialized without infringing on existing intellectual property rights.
• Patent Protection Patent application and protection services for UP Manila innovations, covering patentability assessment, filing, and prosecution.
• Copyright Registration Copyright registration services for creative works and software developed by UP Manila faculty, researchers, and students.
• Trademark Registration Trademark registration services for protecting UP Manila brands, marks, and product identities.
• Industrial Design Registration Industrial design protection services for product designs and appearances developed by UP Manila researchers.
• Utility Model Registration Utility model protection services for incremental innovations and improvements developed by UP Manila researchers.
• Business Development Business development services to connect UP Manila innovations with industry partners and commercialization opportunities through strategic matchmaking.

Quantifiable outcome

• 9 awardees from UPM at the 6th Invention Disclosure Incentive Awards (2021), including 4 disclosures from collaborations with UP Diliman.
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered core, flagship and minor.

• Philippine Council for Health Research and Development (PCHRD) – Intellectual Property and Technology Management (IPTM)coreStrategic or Co-development Partner · 14 May 2026PCHRD-IPTM co-organized TeknoLusugan 2026 as part of the Philippine Health Research Innovations Matching Event (PHRIME), supporting UP Manila's technology transfer objectives and facilitating matching of UP Manila-developed and DOST-funded technologies with industry partners.
• World Intellectual Property Organization (WIPO)coreStrategic or Co-development Partner · 5 February 2026WIPO delegates participated in the 2nd ASEAN Technology and Innovation Support Center (TISC) Network Task Force Meeting and WIPO TISC Regional Meeting held at the UP Manila Museum of a History of Ideas on February 5, 2026, alongside ASEAN Member States delegates and IPOPHL officials.
• Siemens HealthineersflagshipStrategic or Co-development Partner · 1 January 2026Siemens Healthineers and UP Manila signed an MOU in January 2026 for the implementation of the Siemens Healthineers Innovation Ecosystem (SHIFT) Capacity Building Program. A three-day workshop titled 'Siemens Healthineers SHIFT: Innovation Capacity Building' was held March 3-5, 2026 at the Museum of a History of Ideas, engaging healthcare providers, academicians, researchers, and industry experts. The program focuses on double diamond innovation methodology, customer desirability, high-fidelity prototyping, and long-term sustainability in healthcare innovation.
• Board of Investments (BOI)coreStrategic or Co-development Partner · 21 August 2024UP Manila and BOI signed an MOU on August 21, 2024, at the AVR Penthouse, Board of Investments, to collaborate on promoting UP Manila herbal medicine innovations nationwide. BOI was represented by Undersecretary and BOI Managing Head Dr. Ceferino S. Rodolfo and Executive Director Ma. Corazon Halili-Dichosa; UP Manila by Chancellor Dr. Michael L. Tee, represented by VC for Research Dr. Leslie Michelle M. Dalmacio and TTBDO Director Lourdes Marie S. Tejero.
• New Marketlink Pharmaceutical Corporation (NMPC)minorOEM/ Whitelabel/ Licensing Partner · 4 December 2020NMPC President and CEO Dr. Francis Wade Z. Gomez shared experiences as a university technology transfer partner during TeknoLusugan 2020, providing industry perspective on the commercialization process.
• D&L Industries Inc.coreStrategic or Co-development Partner · 27 November 2020Memorandum of Agreement signed November 27, 2020 with D&L Industries Inc. represented by President and CEO Alvin Lao, Managing Director Dean Lao Jr. (Chemrez Technologies), Technical Director Sonia Salvador, and Technical Director Glenn Apostol, for technology development collaboration.
• Greenext Lifescience Corporation (GLC)coreOEM/ Whitelabel/ Licensing Partner · 25 November 2020Licensing Agreement signed November 25, 2020 between UP Manila and Greenext Lifescience Corporation for the Hemoxyther technology for hematologic disorders. GLC President Noel C. Morada represented the company at the virtual ceremonial signing facilitated by UPM-TTBDO.
• Rohto Pharmaceuticals Co. Ltd.coreStrategic or Co-development Partner · 25 November 2020Research Collaboration Agreement signed November 25, 2020 with Rohto Pharmaceuticals Co. Ltd., represented by Research and Development Group Leader Takahiro Kurose, for joint development of health technologies.
• Pivotal Peak Digital Health Solutions, Inc. (PPDHSI)minorOEM/ Whitelabel/ Licensing PartnerHomegrown UP Manila startup that commercializes the Community Health Information Tracking System (CHITS), currently deployed to several Local Government Units across the Philippines for electronic medical records management.
• Philippine Institute of Traditional and Alternative Healthcare (PITAHC)minorChannel Partner/ Reseller/ DistributorPITAHC Director General Dr. Annabelle Pabiona-De Guzman participated in TeknoLusugan 2020 to discuss healthcare innovation through herbal medicine and PITAHC programs encouraging industries to venture into herbal medicine business.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Harvard Office of Technology Development: Harvard OTD manages IP and technology transfer for Harvard University research, including substantial biomedical and health innovation outputs. It is a direct peer as a university TTO with a similar structure and emphasis on health sector commercialization.
• Cambridge Enterprise: Cambridge Enterprise is the technology transfer and enterprise arm of the University of Cambridge. It is a direct peer as a university TTO providing IP protection, licensing, and commercialization services for university research, including substantial health and biotech activity.
• Oxford University Innovation: Oxford University Innovation is the technology transfer company for the University of Oxford, managing IP, licensing, and startup creation from Oxford research. It is a direct peer given its comparable mandate to commercialize university innovations including in life sciences and health.
• MIT Technology Licensing Office: MIT TLO manages intellectual property and licensing for MIT's research outputs. It is a direct peer as a university technology transfer office with a comparable mandate to commercialize faculty innovations, including substantial health and biotech activity.
• Johns Hopkins Technology Ventures: JHTV is the technology transfer arm of Johns Hopkins University, with particular focus on biomedical and health innovations. It is a direct peer given its health-focused portfolio, similar seek-secure-commercialize mandate, and active licensing relationships with pharma and medtech industry partners.
• Stanford Office of Technology Licensing: Stanford OTL is the technology transfer office for Stanford University, managing IP and licensing for one of the world's leading research universities. It is a direct peer to UPM-TTBDO given its mandate to commercialize university-developed innovations across multiple disciplines, including health and life sciences.
• Duke Office of Licensing & Ventures: Duke OLV handles technology transfer for Duke University, with strong focus on health and biomedical innovations from Duke's medical school. It is a direct peer as a health-focused university TTO with a similar mandate to commercialize university-developed health technologies.
• Imperial College Innovations: Imperial College Innovations is the technology transfer office for Imperial College London, with strong focus on health, engineering, and science innovations. It is a direct peer as a university TTO with comparable mandate and similar IP protection/licensing services.

Regional players

• A*STAR: A*STAR is Singapore's public sector R&D agency that supports research commercialization and industry partnerships. It is a regional peer given its similar mandate to advance national health research commercialization, though it operates at a national rather than university level.

Broad incumbents

• AUTM: AUTM is the Association of University Technology Managers, the leading industry association for academic technology transfer. It is a broad incumbent as a peer ecosystem organization to UPM-TTBDO via its role in setting TTO standards and providing professional development, though it is an association rather than a competing TTO.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/upmttbdo
• Facebookfacebook.com/ttbdo
• LinkedInlinkedin.com/company/upm-ttbdo

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of the Philippines Manila Technology Transfer and Business Development Office